Delcath Systems, Inc.

Delcath Systems, Inc. Estimates – SWB:DV3R
TradingView · 23 Oct 2026
Delcath to present cancer treatment data at ESMO conference By Investing.com
Investing.com Nigeria · 19 Oct 2026
Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
www.marketscreener.com · 19 Oct 2026
Ownership limits block all warrant exercises for Delcath Systems (DCTH) shareholder Rosalind.
Stock Titan · 19 Oct 2026
Form 4 Delcath Systems Inc: Rosalind Advisors, Inc. (Director) For: 13 October
Investing.com India · 15 Oct 2026
Delcath Systems Q2 2026 Earnings Call Transcript
Benzinga · 06 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.